google.com
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr RSS 源
直接获取 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的最新更新，更新一发布就能看到。
最新文章
在常用阅读平台获取 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr
类似的 RSS 源
-
Aprea Therapeutics News Releases ir.aprea.com
-
AbbVie News Center news.abbvie.com
- Latest Sanofi Press Releases and News | Sanofi sanofi.com
-
KFF Health News kffhealthnews.org
-
ClinicalTrials.gov: Atopic Dermatitis | Last update posted in the last 14 days clinicaltrials.gov
-
Recently Published Human Medicines hma.eu
-
Public Health Agency of Canada - Updates canada.ca
-
EC Decisions concerning medicinal products ec.europa.eu
问题
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的 RSS 订阅源网址是什么？
订阅源地址为 https://www.google.com/alerts/feeds/11317382618987300685/7968218245088029816。将其粘贴到任意 RSS 阅读器中，或点击“立即关注”在 Feeder 中阅读。
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 多久发布一次？
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的发布频率为 每天约 3 次。 最近一篇文章发布于 about 16 hours前。
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的 RSS 订阅源是否正常？
是的。Feeder 于 4 minutes前检查过，订阅源响应正常。
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 主要发布什么内容？
Feeder 将其归类为 健康。
如何在 Feeder 中关注 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr？
点击“立即关注”；如果还没有账户，请先注册。 Feeder 免费套餐最多支持 200 个订阅源，可在网页、iPhone 和 Android 上使用。无需信用卡。
在 Feeder 中关注 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr
Feeder 免费套餐最多支持 200 个订阅源，可在网页、iPhone 和 Android 上使用。无需信用卡。